首页> 外文OA文献 >Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy

【2h】

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy

机译：增加利巴韦林生物利用度与Telaprevir联合用于丙型肝炎患者用聚乙二醇化 - 干扰素/利巴韦林/ Telaprevir三联疗法治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Pradat; Virlogeux; Maynard; Leclercq; Hatu; Amiri; Lebosse; Miailhes; Zoulim; Gagnieu; Bailly;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. INCREASED RIBAVIRIN BIOAVAILABILITY ASSOCIATED WITH TELAPREVIR USE IN HEPATITIS C PATIENTS TREATED WITH PEGYLATED -INTERFERON/RIBAVIRIN/TELAPREVIR TRIPLE THERAPY [J] . PRADAT PIERRE, VIRLOGEUX VICTOR, MAYNARD MARIANNE, Hepatitis Monthly . 2015,第9期

机译：特拉维夫在聚乙二醇干扰素/利巴韦林/特拉维夫三联疗法治疗的丙型肝炎患者中的利巴韦林生物利用度增加
2. Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation [J] . Kawaoka Tomokazu, Takahashi Shoichi, Tatsukawa Yumiko, Hepatology research: the official journal of the Japan Society of Hepatology . 2014,第12期

机译：活体供者肝移植后复发治疗丙型肝炎的两名患者接受了聚乙二醇干扰素/利巴韦林/特拉帕韦三联疗法治疗
3. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy [J] . MurataM., FurusyoN., OgawaE., Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy . 2014,第5a6期

机译：通过基于telaprevir的三联疗法24周成功消灭丙型肝炎病毒/人免疫缺陷病毒合并感染的血友病患者，以前曾使用聚乙二醇化干扰素-α和利巴韦林治疗失败的成功案例
4. High Prevalence of Fatigue and Depression in HIV/Hepatitis C Co-infected Patients Treated with Pegylated Interferon/ Ribavirin [C] . K. Jones, A. Talal, S. Ferrando International AIDS Conference . 2004

机译：用聚乙二醇化干扰素/利巴韦林治疗的艾滋病毒/丙型肝炎COR感染患者疲劳和抑郁症高患病率
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy [O] . Pierre Pradat, Victor Virlogeux, Marianne Maynard, 2015

机译：在聚乙二醇化干扰素/利巴韦林/特拉普韦三联疗法治疗的丙型肝炎患者中利巴韦林的生物利用度与特拉帕韦相关的增加
7. IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C [O] . Chayama, Kazuaki, Hayes, C. Nelson, Abe, Hiromi, 2011

机译：IL28B但不是ITPA多态性可预测1型丙型肝炎患者对聚乙二醇化干扰素，利巴韦林和特拉帕韦三联疗法的反应

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy

著录项

相似文献

相关主题

期刊订阅